Filing Details

Accession Number:
0001225208-10-002941
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-02 12:00:00
Reporting Period:
2010-02-01
Filing Date:
2010-02-02
Accepted Time:
2010-02-02 10:08:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
901219 Human Genome Sciences Inc HGSI In Vitro & In Vivo Diagnostic Substances (2835) 223178468
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191234 D. Susan Bateson 14200 Shady Grove Road
Rockville MD 20850
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-01 20,000 $12.56 80,358 No 4 M Direct
Common Stock Disposition 2010-02-01 20,000 $26.49 60,358 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option - Right to Buy Disposition 2010-02-01 20,000 $0.00 20,000 $12.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
49,354 2015-01-17 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 12/10/09.
  2. This transaction was executed in multiple trades at prices ranging from $26.40 to $26.59. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
  3. One-eighth of the options granted on January 17, 2005, vested on the six-month anniversary date (July 17, 2005) and the remaining options granted vested monthly on a ratable basis for the next 42 months commencing on August 17, 2005.